Kiniksa Pharmaceuticals International Plc (KNSA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 175,677 | 189,952 | 165,596 | 174,858 | 192,037 |
| Marketable Securities | 350,251 | 278,141 | 248,478 | 177,244 | 115,745 |
| Receivables | 23,490 | 23,224 | 15,594 | 51,742 | 31,910 |
| Inventories | 70,930 | 73,141 | 54,895 | 41,396 | 48,181 |
| TOTAL | $668,633 | $594,172 | $527,177 | $475,530 | $420,311 |
| Non-Current Assets | |||||
| PPE Net | 2,575 | 1,986 | 1,943 | 1,655 | 1,076 |
| Intangibles | 14,750 | 15,000 | 15,250 | 15,500 | 15,750 |
| Other Non-Current Assets | 210,152 | 214,122 | 219,263 | 219,648 | 224,013 |
| TOTAL | $227,477 | $231,108 | $236,456 | $236,803 | $240,839 |
| Total Assets | $896,110 | $825,280 | $763,633 | $712,333 | $661,150 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 12,404 | 24,402 | 2,028 | 6,150 | 8,956 |
| Accrued Expenses | 134,779 | 108,348 | 112,035 | 94,223 | 88,348 |
| Other current liabilities | 20,052 | 20,691 | 22,134 | 20,523 | 18,001 |
| TOTAL | $171,247 | $156,611 | $139,184 | $123,592 | $117,827 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 38,903 | 31,171 | 25,032 | 21,547 | 16,505 |
| TOTAL | $70,714 | $62,982 | $56,843 | $53,358 | $48,316 |
| Total Liabilities | $241,961 | $219,593 | $196,027 | $176,950 | $166,143 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 78,024 | 76,938 | 76,535 | 75,796 | 74,108 |
| Common Shares | 21 | 21 | 21 | 21 | 21 |
| Retained earnings | -414,114 | -439,546 | -462,138 | -476,337 | -494,772 |
| Other shareholders' equity | -1,380 | -665 | -25 | -155 | -53 |
| TOTAL | $654,149 | $605,687 | $567,606 | $535,383 | $495,007 |
| Total Liabilities And Equity | $896,110 | $825,280 | $763,633 | $712,333 | $661,150 |